|
Topic 01: GI Pharmacology Update
Wednesday, August 28, 2024
Speaker: Dr. Peter S. Buch
Credit hours: 4
ACPE UAN: 0741-0000-24-034-H01-P
Learning objectives
- Assessing Abdominal Pain: A Practical Review:
- Define the appropriate workup for several interactive cases of acute abdominal pain.
- Illustrate the pitfalls in making a diagnosis.
- Clinical Dilemmas in GI Bleeding:
- Describe the limitations of colonoscopy.
- Recognize the importance of “Alarm Symptoms”.
- Describe advanced endoscopic techniques that are used to evaluate GI bleeding.
- Recognize the safe use of anti platelet and anticoagulation medications post GI bleeding.
- Colon Cancer Evaluation and Prevention: What’s New?
- State the best practices that lead to colon cancer prevention.
- Review types of polyps and their consequences.
- Review the pitfalls of colonoscopy screening.
- Show reasonable alternatives to colonoscopy.
- Peptic Ulcer Disease and Helicobacter Highlights:
- Identify the importance of risk factors in the development of UGI bleeding.
- Select appropriate candidates for long term PPI therapy.
- Review noninvasive ways of making a H pylori diagnosis.
- Manage antibiotic therapy for Helicobacter 2024.
|
|
Topic 02: An Evidence-Based Approach to Treating T2D in Adults
Wednesday, August 28, 2024
Speaker: Dr. C. Wayne Weart
Credit hours: 2
ACPE UAN: 0741-0000-24-035-H01-P
Learning objectives
- Describe the 2024 American Diabetes Association Standards of Care for Patients with Diabetes and the evidence on which they are based.
- Apply the results of landmark diabetes trials that established improved glycemic control reduces the risk of diabetes-related complications in patients with T2D
- Apply the evolving paradigm by which the treatment of T2D (A1C reduction) has shifted to an outcome-based approach focused on risk reduction, particularly in older patients with established CVD, HF, CKD and/or Obesity.
|
|
Topic 03: Chronic Kidney Disease Pharmacotherapy
Wednesday, August 28, 2024
Speaker: Dr. Sheryl Vondracek
Credit hours: 2
ACPE UAN: 0741-0000-24-036-H01-P
Learning objectives
- Discuss the mechanisms of action, role and pros/cons of SGLT2-inhibitors, GLP-1 inhibitors and finerenone in the prevention of CKD progression.
- Describe the mechanisms of action, role and pros/cons of therapies for the management of hyperkalemia in patients with CKD.
- Choose appropriate therapy for the management of hyperkalemia in a patient with CKD.
- Describe the mechanisms of action, role, and pros/cons of therapies for the management of anemia in patients with CKD.
- Initiate appropriate iron and ESA therapy in a patient with anemia and CKD.
- Discuss the roles of phosphate, calcium, vitamin D and parathyroid hormone in the development of Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)
- Describe the mechanisms of action, and pros/cons of therapies for the management of CKD-MBD.
- Choose an appropriate therapy for the management of hyperphosphatemia, low vitamin D and secondary hyperparathyroidism in a patient with CKD.
|
|
Topic 04:Treatment of Alzheimer’s, Depression and Adult Onset ADHD/ADD
Thursday, August 29, 2024
Speaker: Dr. Joshua Caballero
Credit hours: 2
ACPE UAN: 0741-0000-24-037-H01-P
Learning objectives
- Alzheimer’s Disease and Depression Treatment
- Explain standard and newer treatment options for cognitive disorders (e.g., Alzheimer’s disease).
- Recognize preferred treatments for managing comorbid psychiatric issues in patients with cognitive disorders.
- Describe how to counsel caregivers and patients regarding treatment options for cognitive disorders.
- ADHD
- Identify differences between stimulant medications and formulations.
- Discuss the utility of using non-stimulants in the treatment of adult ADHD.
- Describe comorbidities that may impact treatment in adult ADH
|
|
Topic 05: AHA/ACC/HFSA Guidelines for the Management of Heart Failure, Lipids, and Blood Pressure
Thursday, August 29, 2024
Speaker: Dr. Joseph Saseen
Credit hours: 2
ACPE UAN: 0741-0000-24-038-H01-P
Learning objectives
- Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, and heart failure.
- Identify the optimal use of combination therapy pharmacotherapy for patients with hypertension, including resistant hypertension.
- Describe the similarities and differences in pharmacotherapy for heart failure with reduced ejection fraction and heart failure with preserved ejection fraction.
- List recommendations from the ACC Expert Consensus Decision Pathway for nonstatins and treatment of hypertriglyceridemia.
- Discuss new and emerging pharmacotherapy options for patients with dyslipidemia.
- Select treatment plans to treat patients with hypertension, heart failure, and/or dyslipidemia.
|
|
Topic 06: Treatment of Anaphylaxis – in Primary care and Acute care and Seizures in Acute care
Thursday, August 29, 2024
Speaker: Dr. Andrea Sikora
Credit hours: 1
ACPE UAN: 0741-0000-24-039-H01-P
Learning objectives
- Review treatment approach for anaphylaxis.
- Create a treatment plan for the acute management of seizures.
- Identify common adverse effects from common anti-epileptic medications.
|
|
Topic 07: Protecting the Vulnerable: Improving Safety of Antimicrobials in the Elderly Population
Thursday, August 29, 2024
Speaker: Dr. Christopher M. Bland
Credit hours: 2
ACPE UAN: 0741-0000-24-040-H01-P
Learning objectives
- Evaluate methods to improve safety of antimicrobial prescribing in the elderly
- Review antimicrobial therapy recommendations within Beers Criteria
- Examine best antimicrobials practices through case application
|
|
Topic 08: Mastering Migraine Management: Update on Current Therapies
Thursday, August 29, 2024
Speaker: Dr. Christopher M. Bland
Credit hours: 1
ACPE UAN: 0741-0000-24-041-H01-P
Learning objectives
- Review current older management strategies for migraine headaches.
- Discuss role of newer agents including botulinum toxin.
- Examine best practices through case application.
|